These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24846110)

  • 1. [Thrombosis and embolism during Diane-35 use: analysis of reports made to the Netherlands Pharmacovigilance Centre Lareb].
    van Hunsel FP; Kant AC; van Puijenbroek EP
    Ned Tijdschr Geneeskd; 2014; 158():A6651. PubMed ID: 24846110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pill matters: targeted research into side effects necessary].
    Rosendaal FR
    Ned Tijdschr Geneeskd; 2014; 158():A7740. PubMed ID: 24846117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reflections after the Diane affair.
    Kant A; van Puijenbroek E; van Hunsel F
    J Thromb Haemost; 2014 Sep; 12(9):1385-7. PubMed ID: 24909698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Too much disclosure of product risks? CBC television, SOGC, and Diane-35.
    Mintzes B; Lexchin J; Lippman A; Ford AR
    J Obstet Gynaecol Can; 2003 Apr; 25(4):268-9; discussion 270-3. PubMed ID: 12679817
    [No Abstract]   [Full Text] [Related]  

  • 5. Diane-35 (cyproterone acetate): safety concerns.
    Wooltorton E
    CMAJ; 2003 Feb; 168(4):455-6. PubMed ID: 12591790
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyproterone acetate-ethinyl estradiol use in a 23-year-old woman with stroke.
    Kromm J; Jeerakathil T
    CMAJ; 2014 Jun; 186(9):690-3. PubMed ID: 24491473
    [No Abstract]   [Full Text] [Related]  

  • 7. [Oral contraceptives, risks and hazards].
    Revuz J
    Ann Dermatol Venereol; 2014 Jan; 141(1):5-6. PubMed ID: 24461087
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyproterone acetate/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy.
    Franks S; Layton A; Glasier A
    Hum Reprod; 2008 Feb; 23(2):231-2. PubMed ID: 18083746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of an anti-androgen combination preparation on the hemostatic system].
    Bruni V; Rosati D; Bucciantini S; Verni A; Abbate R; Pinto S; Costanzo G; Costanzo M
    Fortschr Med; 1987 Jan; 105(3):55-8. PubMed ID: 3557259
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyproterone acetate and ethinylestradiol-induced pill oesophagitis: a case report.
    Gulsen MT; Buyukberber NM; Karaca M; Kadayifci A
    Int J Clin Pract Suppl; 2005 Apr; (147):79-81. PubMed ID: 15875632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-use risks.
    Rowe TC
    CMAJ; 2003 May; 168(11):1394. PubMed ID: 12771065
    [No Abstract]   [Full Text] [Related]  

  • 12. [Suspension of Diane35 and its generics: an over-reaction by the French National Medicines Agency (ANSM) unfounded in the light of proven or accepted medical knowledge].
    Debarre JM
    Ann Dermatol Venereol; 2013; 140(6-7):474-8. PubMed ID: 23773753
    [No Abstract]   [Full Text] [Related]  

  • 13. [The hypocrisy of Diane®].
    Revuz J
    Ann Dermatol Venereol; 2013 Apr; 140(4):249-50. PubMed ID: 23567222
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effectiveness of oral cyproterone acetate in combination with ethinylestradiol in acne tarda of the facial type].
    Gollnick H; Albring M; Brill K
    Ann Endocrinol (Paris); 1999 Sep; 60(3):157-66. PubMed ID: 10520404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of an open one-year study with Diane-35 in women with polycystic ovarian syndrome.
    Golland IM; Elstein ME
    Ann N Y Acad Sci; 1993 May; 687():263-71. PubMed ID: 8323182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of Diane-35 and metformin in treatment of polycystic ovary syndrome: an updated systematic review.
    Jing Z; Liang-Zhi X; Tai-Xiang W; Ying T; Yu-Jian J
    Gynecol Endocrinol; 2008 Oct; 24(10):590-600. PubMed ID: 19012104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diane].
    Hansted B; Reymann F
    Ugeskr Laeger; 1983 Aug; 145(31):2391-2. PubMed ID: 6623686
    [No Abstract]   [Full Text] [Related]  

  • 18. [Long-term side-effects following cyproterone acetate containing therapy in gynecology].
    Regidor PA; Speer K; Regidor M; Schindler EM
    Zentralbl Gynakol; 2000; 122(5):268-73. PubMed ID: 10857213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic risk minimization for Diane-35 and generics.
    Bezemer ID; Smits E; Penning-van Beest FJA; Asiimwe A; Herings RMC
    Pharmacoepidemiol Drug Saf; 2017 Nov; 26(11):1411-1417. PubMed ID: 28952198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical experience with Diane-35, currently the lowest dose antiandrogenic hormonal ovulation inhibitor, in mild to moderative androgenization in the female].
    Kaiser E
    Geburtshilfe Frauenheilkd; 1986 Oct; 46(10):738-42. PubMed ID: 2948866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.